CorMedix (CRMD) Goodwill & Intangibles (2019 - 2025)
CorMedix's (CRMD) quarterly Goodwill & Intangibles came in at $423.1 million in Q4 2025, up 21055.1% year-on-year from N/an in Q4 2024, and up 2.84% quarter-over-quarter from $411.4 million in Q3 2025.
CorMedix (CRMD) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
CorMedix has disclosed Goodwill & Intangibles across 4 years of filings, most recently posting $423.1 million for Q4 2025.
- Goodwill & Intangibles for Q4 2025 came in at $423.1 million, up 21055.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $423.1 million (up 21055.1% YoY), and the FY2025 annual result was $423.1 million, up 21055.1% from the prior year.
- Goodwill & Intangibles came in at $423.1 million for Q4 2025 at CorMedix, up from $411.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $423.1 million in Q4 2025 to a low of $1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 423.10 Mn |
| Sep 30, 2025 | 411.42 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2020 | 372,454.00 |
| Jun 30, 2020 | 296,574.00 |
| Dec 31, 2019 | 10,081.00 |